LIVIVO - The Search Portal for Life Sciences

zur deutschen Oberfläche wechseln
Advanced search

Search results

Result 1 - 7 of total 7

Search options

  1. Article: Optimising the zebrafish Cre/Lox toolbox. Codon improved iCre, new gateway tools, Cre protein and guidelines.

    Tromp, Alisha / Wang, Haitao / Hall, Thomas E / Mowry, Bryan / Giacomotto, Jean

    Frontiers in physiology

    2023  Volume 14, Page(s) 1221310

    Abstract: We recently introduced the Cre/Lox technology in our laboratory for both transient (mRNA injections) and stable/transgenic experiments. We experienced significant issues such as silencing, mosaicism, and partial recombination using both approaches. ... ...

    Abstract We recently introduced the Cre/Lox technology in our laboratory for both transient (mRNA injections) and stable/transgenic experiments. We experienced significant issues such as silencing, mosaicism, and partial recombination using both approaches. Reviewing the literature gave us the impression that these issues are common among the zebrafish community using the Cre/Lox system. While some researchers took advantage of these problems for specific applications, such as cell and lineage tracing using the Zebrabow construct, we tried here to improve the efficiency and reliability of this system by constituting and testing a new set of tools for zebrafish genetics. First, we implemented a codon-improved Cre version (iCre) designed for rodent studies to counteract some of the aforementioned problems. This eukaryotic-like iCre version was engineered to i) reduce silencing, ii) increase mRNA stability, iii) enhance translational efficiency, and iv) improve nuclear translocation. Second, we established a new set of tol2-kit compatible vectors to facilitate the generation of either iCre-mRNA or iCre-transgenes for transient and transgenic experiments, respectively. We then validated the use of this material and are providing tips for users. Interestingly, during the validation steps, we found that maternal iCRE-mRNA and/or protein deposition from female transgenics systematically led to complete/homogeneous conversion of all tested Lox-responder-transgenes, as opposed to some residual imperfect conversion when using males-drivers or mRNA injections. Considering that we did not find any evidence of Cre-protein soaking and injections in the literature as it is usually conducted with cells, we tested these approaches. While soaking of cell-permeant CRE-protein did not lead to any detectable Lox-conversion, 1ng-10 ng protein injections led to robust and homogeneous Lox-recombination, suggesting that the use of protein could be a robust option for exogenous delivery. This approach may be particularly useful to manipulate housekeeping genes involved in development, sex determination and reproduction which are difficult to investigate with traditional knockout approaches. All in all, we are providing here a new set of tools that should be useful in the field.
    Language English
    Publishing date 2023-08-02
    Publishing country Switzerland
    Document type Journal Article
    ZDB-ID 2564217-0
    ISSN 1664-042X
    ISSN 1664-042X
    DOI 10.3389/fphys.2023.1221310
    Database MEDical Literature Analysis and Retrieval System OnLINE

    More links

    Kategorien

  2. Article ; Online: Neurexins in autism and schizophrenia-a review of patient mutations, mouse models and potential future directions.

    Tromp, Alisha / Mowry, Bryan / Giacomotto, Jean

    Molecular psychiatry

    2020  Volume 26, Issue 3, Page(s) 747–760

    Abstract: Mutations in the family of neurexins (NRXN1, NRXN2 and NRXN3) have been repeatedly identified in patients with autism spectrum disorder (ASD) and schizophrenia (SCZ). However, it remains unclear how these DNA variants affect neurexin functions and ... ...

    Abstract Mutations in the family of neurexins (NRXN1, NRXN2 and NRXN3) have been repeatedly identified in patients with autism spectrum disorder (ASD) and schizophrenia (SCZ). However, it remains unclear how these DNA variants affect neurexin functions and thereby predispose to these neurodevelopmental disorders. Understanding both the wild-type and pathologic roles of these genes in the brain could help unveil biological mechanisms underlying mental disorders. In this regard, numerous studies have focused on generating relevant loss-of-function (LOF) mammalian models. Although this has increased our knowledge about their normal functions, the potential pathologic role(s) of these human variants remains elusive. Indeed, after reviewing the literature, it seems apparent that a traditional LOF-genetic approach based on complete LOF might not be sufficient to unveil the role of these human mutations. First, these genes present a very complex transcriptome and total-LOF of all isoforms may not be the cause of toxicity in patients, particularly given evidence that causative variants act through haploinsufficiency. Moreover, human DNA variants may not all lead to LOF but potentially to intricate transcriptome changes that could also include the generation of aberrant isoforms acting as a gain-of-function (GOF). Furthermore, their transcriptomic complexity most likely renders them prone to genetic compensation when one tries to manipulate them using traditional site-directed mutagenesis approaches, and this could act differently from model to model leading to heterogeneous and conflicting phenotypes. This review compiles the relevant literature on variants identified in human studies and on the mouse models currently deployed, and offers suggestions for future research.
    MeSH term(s) Autism Spectrum Disorder/genetics ; Autistic Disorder ; Humans ; Mice ; Mutation/genetics ; Nerve Tissue Proteins/genetics ; Schizophrenia/genetics ; Animals
    Chemical Substances Nerve Tissue Proteins
    Language English
    Publishing date 2020-11-15
    Publishing country England
    Document type Journal Article ; Research Support, Non-U.S. Gov't ; Review
    ZDB-ID 1330655-8
    ISSN 1476-5578 ; 1359-4184
    ISSN (online) 1476-5578
    ISSN 1359-4184
    DOI 10.1038/s41380-020-00944-8
    Database MEDical Literature Analysis and Retrieval System OnLINE

    More links

    Kategorien

  3. Article ; Online: Pipeline for generating stable large genomic deletions in zebrafish, from small domains to whole gene excisions.

    Tromp, Alisha / Robinson, Kate / Hall, Thomas E / Mowry, Bryan / Giacomotto, Jean

    G3 (Bethesda, Md.)

    2021  Volume 11, Issue 12

    Abstract: Here we describe a short feasibility study and methodological framework for the production of stable, CRISPR/Cas9-based, large genomic deletions in zebrafish, ranging from several base pairs (bp) to hundreds of kilobases (kb). Using a cocktail of four ... ...

    Abstract Here we describe a short feasibility study and methodological framework for the production of stable, CRISPR/Cas9-based, large genomic deletions in zebrafish, ranging from several base pairs (bp) to hundreds of kilobases (kb). Using a cocktail of four single guide RNAs (sgRNAs) targeting a single genomic region mixed with a marker-sgRNA against the pigmentation gene tyrosinase, we demonstrate that one can easily and accurately excise genomic regions such as promoters, protein domains, specific exons, or whole genes. We exemplify this technique with a complex gene family, neurexins, composed of three duplicated genes with multiple promoters and intricate splicing processes leading to thousands of isoforms. We precisely deleted small regions such as their transmembrane domains (150 bp deletion in average) to their entire genomic locus (300 kb deletion for nrxn1a for instance). We find that both the concentration and ratio of Cas9/sgRNAs are critical for the successful generation of these large deletions and, interestingly, that in our study, their transmission frequency does not seem to decrease with increasing distance between sgRNA target sites. Considering the growing reports and debate about genetically compensated small indel mutants, the use of large-deletion approaches is likely to be widely adopted in studies of gene function. This strategy will also be key to the study of non-coding genomic regions. Note that we are also describing here a custom method to produce the sgRNAs, which proved to be faster and more robust than the ones traditionally used in the community to date.
    MeSH term(s) Animals ; CRISPR-Cas Systems ; Exons ; Genomics ; RNA, Guide, CRISPR-Cas Systems/genetics ; Zebrafish/genetics
    Chemical Substances RNA, Guide, CRISPR-Cas Systems
    Language English
    Publishing date 2021-09-08
    Publishing country England
    Document type Journal Article ; Research Support, Non-U.S. Gov't
    ZDB-ID 2629978-1
    ISSN 2160-1836 ; 2160-1836
    ISSN (online) 2160-1836
    ISSN 2160-1836
    DOI 10.1093/g3journal/jkab321
    Database MEDical Literature Analysis and Retrieval System OnLINE

    More links

    Kategorien

  4. Article ; Online: Tmem2 Regulates Embryonic Vegf Signaling by Controlling Hyaluronic Acid Turnover.

    De Angelis, Jessica E / Lagendijk, Anne K / Chen, Huijun / Tromp, Alisha / Bower, Neil I / Tunny, Kathryn A / Brooks, Andrew J / Bakkers, Jeroen / Francois, Mathias / Yap, Alpha S / Simons, Cas / Wicking, Carol / Hogan, Benjamin M / Smith, Kelly A

    Developmental cell

    2017  Volume 40, Issue 4, Page(s) 421

    Language English
    Publishing date 2017-02-27
    Publishing country United States
    Document type Published Erratum
    ZDB-ID 2054967-2
    ISSN 1878-1551 ; 1534-5807
    ISSN (online) 1878-1551
    ISSN 1534-5807
    DOI 10.1016/j.devcel.2017.02.005
    Database MEDical Literature Analysis and Retrieval System OnLINE

    More links

    Kategorien

  5. Article ; Online: Tmem2 Regulates Embryonic Vegf Signaling by Controlling Hyaluronic Acid Turnover.

    De Angelis, Jessica E / Lagendijk, Anne K / Chen, Huijun / Tromp, Alisha / Bower, Neil I / Tunny, Kathryn A / Brooks, Andrew J / Bakkers, Jeroen / Francois, Mathias / Yap, Alpha S / Simons, Cas / Wicking, Carol / Hogan, Benjamin M / Smith, Kelly A

    Developmental cell

    2016  Volume 40, Issue 2, Page(s) 123–136

    Abstract: Angiogenesis is responsible for tissue vascularization during development, as well as in pathological contexts, including cancer and ischemia. Vascular endothelial growth factors (VEGFs) regulate angiogenesis by acting through VEGF receptors to induce ... ...

    Abstract Angiogenesis is responsible for tissue vascularization during development, as well as in pathological contexts, including cancer and ischemia. Vascular endothelial growth factors (VEGFs) regulate angiogenesis by acting through VEGF receptors to induce endothelial cell signaling. VEGF is processed in the extracellular matrix (ECM), but the complexity of ECM control of VEGF signaling and angiogenesis remains far from understood. In a forward genetic screen, we identified angiogenesis defects in tmem2 zebrafish mutants that lack both arterial and venous Vegf/Vegfr/Erk signaling. Strikingly, tmem2 mutants display increased hyaluronic acid (HA) surrounding developing vessels. Angiogenesis in tmem2 mutants was rescued, or restored after failed sprouting, by degrading this increased HA. Furthermore, oligomerized HA or overexpression of Vegfc rescued angiogenesis in tmem2 mutants. Based on these data, and the known structure of Tmem2, we find that Tmem2 regulates HA turnover to promote normal Vegf signaling during developmental angiogenesis.
    MeSH term(s) Animals ; Arteries/metabolism ; Embryo, Nonmammalian/metabolism ; Endothelial Cells/metabolism ; Hyaluronic Acid/metabolism ; Membrane Proteins/chemistry ; Membrane Proteins/metabolism ; Mutation/genetics ; Neovascularization, Physiologic ; Phenotype ; Polymerization ; Signal Transduction ; Torso/blood supply ; Vascular Endothelial Growth Factor A/metabolism ; Veins/metabolism ; Zebrafish/embryology ; Zebrafish/metabolism ; Zebrafish Proteins/chemistry ; Zebrafish Proteins/metabolism
    Chemical Substances Membrane Proteins ; Vascular Endothelial Growth Factor A ; Zebrafish Proteins ; cemip2 protein, zebrafish ; Hyaluronic Acid (9004-61-9)
    Language English
    Publishing date 2016-11-14
    Publishing country United States
    Document type Journal Article ; Comment
    ZDB-ID 2054967-2
    ISSN 1878-1551 ; 1534-5807
    ISSN (online) 1878-1551
    ISSN 1534-5807
    DOI 10.1016/j.devcel.2016.12.017
    Database MEDical Literature Analysis and Retrieval System OnLINE

    More links

    Kategorien

  6. Article ; Online: Repositioning drugs for inflammatory disease - fishing for new anti-inflammatory agents.

    Hall, Christopher J / Wicker, Sophie M / Chien, An-Tzu / Tromp, Alisha / Lawrence, Lisa M / Sun, Xueying / Krissansen, Geoffrey W / Crosier, Kathryn E / Crosier, Philip S

    Disease models & mechanisms

    2014  Volume 7, Issue 9, Page(s) 1069–1081

    Abstract: Inflammation is an important and appropriate host response to infection or injury. However, dysregulation of this response, with resulting persistent or inappropriate inflammation, underlies a broad range of pathological processes, from inflammatory ... ...

    Abstract Inflammation is an important and appropriate host response to infection or injury. However, dysregulation of this response, with resulting persistent or inappropriate inflammation, underlies a broad range of pathological processes, from inflammatory dermatoses to type 2 diabetes and cancer. As such, identifying new drugs to suppress inflammation is an area of intense interest. Despite notable successes, there still exists an unmet need for new effective therapeutic approaches to treat inflammation. Traditional drug discovery, including structure-based drug design, have largely fallen short of satisfying this unmet need. With faster development times and reduced safety and pharmacokinetic uncertainty, drug repositioning - the process of finding new uses for existing drugs - is emerging as an alternative strategy to traditional drug design that promises an improved risk-reward trade-off. Using a zebrafish in vivo neutrophil migration assay, we undertook a drug repositioning screen to identify unknown anti-inflammatory activities for known drugs. By interrogating a library of 1280 approved drugs for their ability to suppress the recruitment of neutrophils to tail fin injury, we identified a number of drugs with significant anti-inflammatory activity that have not previously been characterized as general anti-inflammatories. Importantly, we reveal that the ten most potent repositioned drugs from our zebrafish screen displayed conserved anti-inflammatory activity in a mouse model of skin inflammation (atopic dermatitis). This study provides compelling evidence that exploiting the zebrafish as an in vivo drug repositioning platform holds promise as a strategy to reveal new anti-inflammatory activities for existing drugs.
    MeSH term(s) Animals ; Anti-Inflammatory Agents/adverse effects ; Anti-Inflammatory Agents/pharmacokinetics ; Anti-Inflammatory Agents/therapeutic use ; Drug Evaluation, Preclinical ; Humans ; Inflammation/drug therapy ; Zebrafish
    Chemical Substances Anti-Inflammatory Agents
    Language English
    Publishing date 2014-07-18
    Publishing country England
    Document type Journal Article ; Research Support, Non-U.S. Gov't
    ZDB-ID 2451104-3
    ISSN 1754-8411 ; 1754-8403
    ISSN (online) 1754-8411
    ISSN 1754-8403
    DOI 10.1242/dmm.016873
    Database MEDical Literature Analysis and Retrieval System OnLINE

    More links

    Kategorien

  7. Article ; Online: Vegfd can compensate for loss of Vegfc in zebrafish facial lymphatic sprouting.

    Astin, Jonathan W / Haggerty, Michael J L / Okuda, Kazuhide S / Le Guen, Ludovic / Misa, June P / Tromp, Alisha / Hogan, Benjamin M / Crosier, Kathryn E / Crosier, Philip S

    Development (Cambridge, England)

    2014  Volume 141, Issue 13, Page(s) 2680–2690

    Abstract: Lymphangiogenesis is a dynamic process that involves the sprouting of lymphatic endothelial cells (LECs) from veins to form lymphatic vessels. Vegfr3 signalling, through its ligand Vegfc and the extracellular protein Ccbe1, is essential for the sprouting ...

    Abstract Lymphangiogenesis is a dynamic process that involves the sprouting of lymphatic endothelial cells (LECs) from veins to form lymphatic vessels. Vegfr3 signalling, through its ligand Vegfc and the extracellular protein Ccbe1, is essential for the sprouting of LECs to form the trunk lymphatic network. In this study we determined whether Vegfr3, Vegfc and Ccbe1 are also required for development of the facial and intestinal lymphatic networks in the zebrafish embryo. Whereas Vegfr3 and Ccbe1 are required for the development of all lymphatic vessels, Vegfc is dispensable for facial lymphatic sprouting but not for the complete development of the facial lymphatic network. We show that zebrafish vegfd is expressed in the head, genetically interacts with ccbe1 and can rescue the lymphatic defects observed following the loss of vegfc. Finally, whereas knockdown of vegfd has no phenotype, double knockdown of both vegfc and vegfd is required to prevent facial lymphatic sprouting, suggesting that Vegfc is not essential for all lymphatic sprouting and that Vegfd can compensate for loss of Vegfc during lymphatic development in the zebrafish head.
    MeSH term(s) Animals ; Calcium-Binding Proteins/metabolism ; DNA Primers/genetics ; In Situ Hybridization ; Lymphangiogenesis/genetics ; Lymphangiogenesis/physiology ; Microscopy, Confocal ; Morpholinos/genetics ; Reverse Transcriptase Polymerase Chain Reaction ; Statistics, Nonparametric ; Vascular Endothelial Growth Factor C/deficiency ; Vascular Endothelial Growth Factor D/metabolism ; Zebrafish/embryology ; Zebrafish Proteins/deficiency ; Zebrafish Proteins/metabolism
    Chemical Substances Calcium-Binding Proteins ; DNA Primers ; Morpholinos ; Vascular Endothelial Growth Factor C ; Vascular Endothelial Growth Factor D ; Zebrafish Proteins ; vascular endothelial growth factor C, zebrafish ; vascular endothelial growth factor D, zebrafish
    Language English
    Publishing date 2014-07
    Publishing country England
    Document type Journal Article ; Research Support, Non-U.S. Gov't
    ZDB-ID 90607-4
    ISSN 1477-9129 ; 0950-1991
    ISSN (online) 1477-9129
    ISSN 0950-1991
    DOI 10.1242/dev.106591
    Database MEDical Literature Analysis and Retrieval System OnLINE

    More links

    Kategorien

To top